Literature DB >> 9790948

Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens.

S Sordello1, N Bertrand, J Plouët.   

Abstract

Evidence from pathophysiological studies support the concept that embryonic development, tumor progression, and hormonally-regulated tissue masses such as adult prostate and corpus luteum are angiogenesis-dependent. We examined if the prostatic expression of vascular endothelial growth factor (VEGF), the major regulator of normal and pathological angiogenesis, was regulated by testosterone. Northern blot of VEGF messenger ribonucleic acid (mRNA) extracted from a human immortalized epithelial prostatic cell line (PNT1) showed that dihydrotestosterone (DHT) up-regulated VEGF mRNA at a level comparable to that observed upon exposure to growth factors. Polymerase chain reaction of reverse transcribed mRNA demonstrated that the ratio of the two splice variants encoding the 121 and 165 isoforms of VEGF were not affected by DHT. VEGF biological activity, measured in the conditioned medium by radio receptor assay, was increased by DHT. Injection of testosterone in adult rats induced a transient increase of the ventral lobe weight and the specific activity of prostatic VEGF, leading to a 7-fold increase in the prostate content of VEGF. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790948     DOI: 10.1006/bbrc.1998.9328

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation.

Authors:  Philip P Fitchev; Susan M Wcislak; Chung Lee; Anders Bergh; Charles B Brendler; Veronica M Stellmach; Susan E Crawford; Constantine D Mavroudis; Mona L Cornwell; Jennifer A Doll
Journal:  Lab Invest       Date:  2010-05-10       Impact factor: 5.662

2.  Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.

Authors:  Gui-Min Wang; Bruce Kovalenko; Yili Huang; David Moscatelli
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

3.  Endothelial cells support the growth of prostate tissue in vivo.

Authors:  Michael Bates; Bruce Kovalenko; E Lynette Wilson; David Moscatelli
Journal:  Prostate       Date:  2008-06-01       Impact factor: 4.104

4.  Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts.

Authors:  Shengqiang Yu; Chiuan-Ren Yeh; Yuanjie Niu; Hong-Chiang Chang; Yu-Chieh Tsai; Harold L Moses; Chih-Rong Shyr; Chawnshang Chang; Shuyuan Yeh
Journal:  Prostate       Date:  2011-07-07       Impact factor: 4.104

5.  The future in advanced prostate cancer: take your partners or is the last dance for me?

Authors:  David I Quinn
Journal:  Rev Urol       Date:  2004

6.  Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism.

Authors:  Jingjing Cai; Yuan Hong; Chunyan Weng; Chen Tan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-21       Impact factor: 4.733

7.  Aging impairs VEGF-mediated, androgen-dependent regulation of angiogenesis.

Authors:  Laura Lecce; Yuen Ting Lam; Laura A Lindsay; Sui Ching Yuen; Philippa J L Simpson; David J Handelsman; Martin K C Ng
Journal:  Mol Endocrinol       Date:  2014-07-24

8.  Progression to androgen-independent LNCaP human prostate tumors: cellular and molecular alterations.

Authors:  Jin-Rong Zhou; Lunyin Yu; Luiz F Zerbini; Towia A Libermann; George L Blackburn
Journal:  Int J Cancer       Date:  2004-07-20       Impact factor: 7.396

Review 9.  Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.

Authors:  Arich Ryan Reynolds; Natasha Kyprianou
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

10.  Sex hormones and mucosal wound healing.

Authors:  Christopher G Engeland; Bahareh Sabzehei; Phillip T Marucha
Journal:  Brain Behav Immun       Date:  2008-12-11       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.